Insider Trading March 31, 2026

Yorktown IX Parings Ramaco Resources Stake in Two March Trades; Generates $111,532

Entity sold 10,325 Class B shares across March 27 and March 30 while retaining more than 1.2 million shares amid mixed company developments

By Priya Menon METC
Yorktown IX Parings Ramaco Resources Stake in Two March Trades; Generates $111,532
METC

Yorktown IX Associates LLC, a 10 percent owner of Ramaco Resources, Inc. (NASDAQ:METC), disposed of 10,325 shares of Class B common stock in two transactions on March 27 and March 30, 2026, receiving roughly $111,532. After the sales, the firm indirectly continues to hold 1,216,317 Class B shares. The trades come as the stock trades at $15.46, reflecting substantial annual gains but steep recent losses, and as the company reports operational improvements, a planned corporate reorganization, ongoing litigation and insider option exercises.

Key Points

  • Yorktown IX Associates LLC sold 10,325 shares of Ramaco Resources Class B common stock on March 27 and March 30, 2026, raising about $111,532.
  • After the trades Yorktown IX still indirectly holds 1,216,317 Class B shares; Ramaco's shares traded at $15.46, up 83% over one year but down 55% over six months, with InvestingPro indicating the stock appears overvalued relative to Fair Value.
  • Ramaco recently reported Q4 2025 results showing strong cost management despite an EPS loss, announced a plan to reorganize into four wholly owned subsidiaries, filed a trade secrets lawsuit against a former employee, and saw CEO Randall W. Atkins exercise long-held 2017 stock options.

Yorktown IX Associates LLC, identified as a 10 percent holder of Ramaco Resources, Inc. (NASDAQ:METC), executed two separate sales of Class B common stock in late March 2026 that together totaled 10,325 shares and produced approximately $111,532 in proceeds.

The block trades were split across two days:

  • March 27, 2026 - 8,059 shares sold at a weighted average price of $10.9327, with transaction prices ranging from $10.55 to $11.285.
  • March 30, 2026 - 2,266 shares sold at a weighted average price of $10.3381, with trade prices between $10.06 and $10.6975.

Following these dispositions, Yorktown IX Associates LLC retains an indirect holding of 1,216,317 shares of Ramaco Resources Class B common stock.

The insider sales coincided with a market price for Ramaco Resources of $15.46. The stock has demonstrated marked volatility: an 83 percent increase over the prior 12 months contrasted with a 55 percent decline over the most recent six-month period. An InvestingPro analysis referenced in company reporting indicates the share price appears overvalued relative to its Fair Value.


Additional company developments noted in recent disclosures provide context but do not directly explain the insider sales. Ramaco Resources published its Q4 2025 results, which highlighted strong cost management and operational resilience despite reporting a loss per share. The company attributed improvements in its financial position to proprietary technology and cost reductions.

Separately, Ramaco Resources announced a corporate reorganization plan that would divide the business into four separate operating divisions, each structured as a wholly owned subsidiary. The firm also initiated legal action by filing a trade secrets lawsuit against a former employee, identified as Alex J. Moyes, alleging misappropriation of trade secrets and breach of contract and seeking various forms of relief, including compensatory and punitive damages.

On the executive front, CEO Randall W. Atkins exercised stock options granted in 2017, resulting in acquisitions of both Class A and Class B shares. These options had been held for more than nine years prior to exercise.

The transactional detail, the company's recent financial narrative and the legal proceedings together create a multifaceted snapshot of Ramaco Resources as of late March 2026. Investors and observers are left to weigh the insider activity alongside the firm-level developments and the stock's divergent short- and long-term performance metrics.

Risks

  • Earnings uncertainty - the company reported a loss per share in Q4 2025 despite operational cost improvements, creating earnings variability that could affect investor returns.
  • Legal exposure - the trade secrets lawsuit against a former employee introduces litigation risk, including potential financial and operational implications if court outcomes are unfavorable.
  • Valuation mismatch - InvestingPro analysis indicates the stock appears overvalued relative to its Fair Value, posing downside risk for equity investors if market sentiment or fundamentals shift.

More from Insider Trading

Alphabet Executive Disposes $2.48M in Class C Shares Amid Ongoing AI Product Updates Mar 31, 2026 Fairmount Funds Sells Cogent Biosciences Stake After Preferred Conversion; FDA Clears Key Filing for Bezuclastinib Mar 31, 2026 Ramaco Director Disposes $3.05M in Shares Amid Volatile Trading Mar 31, 2026 Abeona CEO Disposes of $131K in Shares as Gene Therapy Commercialization Begins Mar 31, 2026 Yorktown Energy Partners Sells 10,465 Shares of Ramaco Resources Mar 31, 2026